Study InformationLast updated: May 22, 2020
Mobile users, please click the menu on the top left.
This site is a data portal to help scientists, researchers, and clinicians mine the human gene expression changes that occur in response to SARS-CoV-2 infection, the pathogenic agent of COVID-19, as well as to provide resources for use of RNA-seq data from clinical cohorts. These data are from the first batch of 735 patient samples (n=216 COVID-19 positive and 519 COVID-19 negative by RT-PCR) described in more detail in our paper here.
Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactionshttps://www.biorxiv.org/content/10.1101/2020.04.20.048066v5
This work is generously supported by Citadel, WorldQuant, the Vallee Foundation, the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR000457), the Core Facilities at Weill Cornell Medicine, the Scientific Computing Unit (SCU) of the ICB, XSEDE Supercomputing Resources, and the National Science Foundation (1840275).
You can download the pre-print version of Supplementary Table 3 & 4 from here. Results are subject to change.Download (26mb)
Unless otherwise noted, all site content is copyrighted by Mason Lab and Weill Cornell Medicine.
The "Weill Cornell Medicine" name, logo, seal are registered trademarks of Cornell University. All rights reserved.